Data as of Aug 29
| +0.10 / +4.57%|
The 3 analysts offering 12-month price forecasts for PharmAthene Inc have a median target of 6.00, with a high estimate of 6.00 and a low estimate of 4.00. The median estimate represents a +162.01% increase from the last price of 2.29.
The current consensus among 3 polled investment analysts is to Buy stock in PharmAthene Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.